About Polks Discount Drugs #2
Polks Discount Drugs #2 is a Pharmaceuticals company, headquartered in Biloxi, with 51 - 200 employees and annual revenue of $0 - $100k.
POLKS DISCOUNT DRUGS #2 is a pharmaceutical retail company based out of 101 49 PL, Florence, Mississippi, United States.
Seamless Pro Tip
Use this information to figure out if this company is an ideal customer for you.
Polks Discount Drugs #2 Company Highlights
Phone Number
(228) 215-xxxx
Corporate Office Address
1845 Popps Ferry Road
Biloxi, 39532
Website
Polks Discount Drugs #2 Org
Polks Discount Drugs #2 has 1 C-Level, 5 Manager, and 20 Other employees.
Polks Discount Drugs #2's Tech Stack
Frequently Asked Questions About
Polks Discount Drugs #2
Log in or sign up to get full contact details and additional support.
How many senior employees does Polks Discount Drugs #2 have?
Polks Discount Drugs #2 has 6 senior employees that are typically used for decision making.
What technologies does Polks Discount Drugs #2 use?
Polks Discount Drugs #2 uses technologies including Google Cloud, Lightbox, and MySQL.
How do I contact Polks Discount Drugs #2?
To contact Polks Discount Drugs #2, visit polksdrugs.com.
What companies are similar to Polks Discount Drugs #2?
Companies similar to Polks Discount Drugs #2 include IA, Advanced Clinical, and Fagron.
Where is Polks Discount Drugs #2 headquartered?
Polks Discount Drugs #2 is headquartered at 1845 Popps Ferry Road, Biloxi.
What is the main phone number for Polks Discount Drugs #2?
The main phone number for Polks Discount Drugs #2 is (228) 215-xxxx.
What is the official website for Polks Discount Drugs #2?
The official website for Polks Discount Drugs #2 is polksdrugs.com.
What is the annual revenue of Polks Discount Drugs #2?
The annual revenue of Polks Discount Drugs #2 is $0 - $100k.
How many employees does Polks Discount Drugs #2 have?
Polks Discount Drugs #2 has 51 - 200 employees.
What industry is Polks Discount Drugs #2 in?
Polks Discount Drugs #2 is in the Pharmaceuticals industry.
Last updated: July 22, 2025